Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of allopregnanolone in women with PMDD, depression, PCOS and oral contraceptives
2004-002540-94Phase 2Completed
- Sponsor
- Norrlands University Hospital
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of brexanolone in Premenstrual Dysphoric Disorder (PMDD), major depressive disorder (MDD) and polycystic ovary syndrome (PCOS), sponsored by Norrlands University Hospital. Primary endpoint: Change in saccadic eye movement velocity. Started Oct 2004; status: completed.
02
Drugs
brexanolone
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)major depressive disorder (MDD)polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on 2004-002540-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002540-94.